ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,549Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 113

$651K Total Retail Price of All Prescriptions

Rank: 12 out of 113

460 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Montana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 460 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 460 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 10,219 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Montana
LEVOTHYROXINE SODIUM 864 735 1 1
LISINOPRIL 531 425 2 3
AMLODIPINE BESYLATE 507 462 3 4
SIMVASTATIN 463 380 4 2
OMEPRAZOLE 427 315 5 5
HYDROCODONE-ACETAMINOPHEN 404 323 S3 6 7
ATORVASTATIN CALCIUM 396 328 7 15
PRAVASTATIN SODIUM 353 288 8 23
METOPROLOL SUCCINATE 268 255 9 10
FUROSEMIDE 248 202 10 6
LOSARTAN POTASSIUM 237 209 11 13
METFORMIN HCL 223 167 12 11
POTASSIUM CHLORIDE 208 188 13 12
HYDROCHLOROTHIAZIDE 202 176 14 9
METOPROLOL TARTRATE 191 139 15 14
LOSARTAN-HYDROCHLOROTHIAZIDE 166 166 16 40
ZOLPIDEM TARTRATE 166 138 16 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 142 18 34
ATENOLOL 139 131 19 16
METFORMIN HCL ER 135 107 20 51
SERTRALINE HCL 134 94 21 21
FLUTICASONE PROPIONATE 130 103 22 39
ALENDRONATE SODIUM 129 125 23 22
GABAPENTIN 125 108 24 18
LANTUS 124 111 25 38
ALLOPURINOL 122 117 26 20
TAMSULOSIN HCL 112 93 27 24
CLOPIDOGREL 106 92 28 56
GLIMEPIRIDE 105 90 29 36
DONEPEZIL HCL 91 91 30 33
CLONIDINE HCL 90 80 31 74
LOVASTATIN 89 60 32 53
WARFARIN SODIUM 87 65 33 8
NAMENDA 77 77 34 48
JANUVIA 76 76 35 85
CRESTOR 73 41 36 30
TRIAMTERENE-HCTZ 72 58 37 26
PAROXETINE HCL 72 67 37 45
CITALOPRAM HBR 67 55 39 17
CARVEDILOL 65 46 40 25
PROPRANOLOL HCL 64 51 41 92
NEXIUM 62 36 42 47
PROAIR HFA 58 33 43 64
RAMIPRIL 58 31 43 116
PLAVIX 57 53 45 81
ACTOS 54 41 46 109
TRAMADOL HCL 53 48 47 29
SPIRONOLACTONE 52 36 48 32
LIPITOR 52 40 48 159
FLUOXETINE HCL 52 33 48 31
GEMFIBROZIL 51 32 51 61
ADVAIR DISKUS 51 51 51 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.